Heligenics, Inc. — Form D
Heligenics, Inc. of LAS VEGAS, NV, a company, filed a Form D exempt-offering notice with the SEC on 2025-01-08. The offering totals $2.6M, of which $2.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-01-08
- Form: D
- Accession: 0001833506-25-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.6M
- Amount sold: $2.6M
- Minimum investment: $10K
- Investors: 8
- Date of first sale: 2024-08-23
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-534598
Issuer
- Name: Heligenics, Inc.
- CIK: 0001833506
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2019
- Address: 10530 DISCOVERY DR, LAS VEGAS, NV, 89135
- Phone: (209) 480-5774
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Martin Schiller | Executive Officer | LAS VEGAS, NV |
| Martin R Schiller | Executive Officer | Las Vegas, NV |
| Lawrence John Loomis | Director | Las Vegas, NV |
| Lawrence John Loomis | Executive Officer | Las Vegas, NV |
Other filings by this issuer (2)
More